Skip to main content

Rapidly Rising Prevalence of Nosocomial Multidrug-Resistant, Gram-Negative Bacilli: A 9-Year Surveillance Study

  • Erika M. C. D'Agata (a1)

To examine and quantify the temporal trends of nosocomial multidrug-resistant, gram-negative bacilli.


A 9-year surveillance study was conducted. Multidrug resistance was defined as resistance to 3 or more antimicrobial classes.


Tertiary-care institution.


From 1994 to 2002, multidrug-resistant, gram-negative bacilli increased from 1% to 16% for multidrug-resistant Pseudomonas aeruginosa, 4% to 13% for multidrug-resistant Enterobacter species, 0.5% to 17% for multidrug-resistant Klebsiella species, 0% to 9% for multidrug-resistant Proteus species, and 0.2% to 4% for multidrug-resistant Escherichia coli (P ≤ .05). The most common pattern of multidrug resistance was co-resistance to quinolones, third-generation cephalosporins, and aminoglycosides.


The rapid rise of multidrug-resistant, gram-negative bacilli may warrant infection control programs to include these pathogens in strategies aimed at limiting the emergence and spread of antimicrobial-resistant pathogens.

Corresponding author
Beth Israel Deaconess Medical Center, Division of Infectious Diseases, 330 Brookline Ave., East Campus Mailstop SL-435G, Boston, MA 02215
Hide All
1.Jarvis WR, Edwards JR, Culver DH, et al.Nosocomial infection rates in adult and pediatric intensive care units in the United States: National Nosocomial Infection Surveillance System. Am J Med 1991;91:185S191S.
2.Gales AC, Jones RN, Turnidge JJ, Rennie R, Ramphai R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32:S146S155.
3.Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DETrends in antimicrobial susceptibilities among Enterobacteriaceae isolates from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 2003;47:16721680.
4.Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DESurveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003;47:16811688.
5.Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst night mare? Clin Infect Dis 2002;34:634640.
6.Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933951.
7.Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 1996;178:58535859.
8.Ziha-Zarifi I, Lianes C, Köhler T, Pechere J, Plesiat P. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa over-expressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother 1999;43:287291.
9.Leverstein-van Hall MA, Blok HEM, Donders AR, et al.Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 2003;187:251259.
10.National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Villanova, PA: National Committee for Clinical Laboratory Standards; 1999.
11.D'Agata E, Venkataraman L, DeGirolami P, Samore M. Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative strains in a non-outbreak setting. J Clin Microbiol 1997;35:26022605.
12.Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother 1994;38:409414.
13.Lidsky K, Hoyen C, Salvator A, Rice LB, Toltzis P. Antibiotic-resistant gram-negative organisms in pediatric chronic-care facilities. Clin Infect Dis 2002;34:760766.
14.D'Agata EM, Venkataraman L, DeGirolami P, Samore M. Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods. J Clin Microbiol 1999;37:30653067.
15.Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000;29:177181.
16.Verweij PE, Bijl D, Melchers WJ, et al.Pseudo-outbreak of multiresis-tant Pseudomonas aeruginosa in a hematology unit. Infect Control Hosp Epidemiol 1997;18:128131.
17.Tacconelli E, Tumbarello M, Bertagnolio S, et al.Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology. Emerg Infect Dis 2002;8:220221.
18.Pirnay JP, De Vos D, Cochez C, et al.Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003;41:11921202.
19.D'Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenover F. The molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a tertiary care hospital. J Infect 1998;36:279285.
20.Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococci, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834844.
21.Arruda EA, Marinho IS, Boulos M, et al.Nosocomial infections caused by multiresistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 1999;20:620623.
22.Eveillard M, Schmit JL, Eb F. Antimicrobial use prior to the acquisition of multiresistant bacteria. Infect Control Hosp Epidemiol 2002;23:155158.
23.Paterson DL, Ko WC, Von Gottberg A, et al.International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004;140:2632.
24.D'Agata EM, Venkataraman L, DeGirolami P, et al.Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med 1999;27:10901095.
25.Muto CA, Jernigan JA, Ostrowsky BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362386.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 8 *
Loading metrics...

Abstract views

Total abstract views: 152 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 15th December 2017. This data will be updated every 24 hours.